Synergistic combinatorial anticancer potential of Tamoxifen with Naringin and Diosmetin in MCF-7 breast cancer cells and their liposomal delivery.

Sci Rep · 2026 · PMC12936089 · PMID 41651903

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Differences were considered significant at p < 0.05 (*), highly significant at p < 0.01 (**), very highly significant at p < 0.001 (***), and extremely significant at p < 0.0001 (****).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.